Sunstone Life Science Ventures
Venture capital
UncertainLast verified 7 Nov 2026
Sunstone Life Science Ventures is a European venture capital firm investing in early-stage life science companies that develop novel therapeutics for humans.
1 deal in the last 24 months, latest 15 Oct 2025. From its website and its deals in the news.
Key facts
- Stages
- Pre-seed, Seed, Series C+
- Sectors
- Biotech & pharma
- Eligible countries
- Not stated
- Provider based in
- Denmark
- Timing
- Rolling applications
- Focus
- early-stage life science; novel therapeutics for humans
- How to apply
- Application form · Apply on their site
- Source
- https://sunstone.eu/
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| Step Pharma · France | Series C+ | Biotech & pharma, Healthtech | €38M | participant | 15 Oct 2025 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Apply link
https://sunstone.eu/contact | Read more…
https://sunstone.eu/ - Kind
Sunstone Life Science Ventures is an independent European venture capital investment firm.
https://sunstone.eu/ - Sectors
Our purpose – and passion – is to seek out, enable and empower the most promising life science therapeutics innovations.
https://sunstone.eu/ - Stages
Sunstone Life Science Ventures invests in early-stage life science companies developing novel therapeutics for humans.
https://sunstone.eu/
Status history
- 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at Sunstone Life Science Ventures? Claim this profile to confirm what you invest in.